Cargando…
Targeting structural features of viral genomes with a nano-sized supramolecular drug
RNA targeting is an exciting frontier for drug design. Intriguing targets include functional RNA structures in structurally-conserved untranslated regions (UTRs) of many lethal viruses. However, computational docking screens, valuable in protein structure targeting, fail for inherently flexible RNA....
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153246/ https://www.ncbi.nlm.nih.gov/pubmed/34123344 http://dx.doi.org/10.1039/d1sc00933h |
_version_ | 1783698757352685568 |
---|---|
author | Melidis, Lazaros Styles, Iain B. Hannon, Michael J. |
author_facet | Melidis, Lazaros Styles, Iain B. Hannon, Michael J. |
author_sort | Melidis, Lazaros |
collection | PubMed |
description | RNA targeting is an exciting frontier for drug design. Intriguing targets include functional RNA structures in structurally-conserved untranslated regions (UTRs) of many lethal viruses. However, computational docking screens, valuable in protein structure targeting, fail for inherently flexible RNA. Herein we harness MD simulations with Markov state modeling to enable nanosize metallo-supramolecular cylinders to explore the dynamic RNA conformational landscape of HIV-1 TAR untranslated region RNA (representative for many viruses) replicating experimental observations. These cylinders are exciting as they have unprecedented nucleic acid binding and are the first supramolecular helicates shown to have anti-viral activity in cellulo: the approach developed in this study provides additional new insight about how such viral UTR structures might be targeted with the cylinder binding into the heart of an RNA-bulge cavity, how that reduces the conformational flexibility of the RNA and molecular details of the insertion mechanism. The approach and understanding developed represents a new roadmap for design of supramolecular drugs to target RNA structural motifs across biology and nucleic acid nanoscience. |
format | Online Article Text |
id | pubmed-8153246 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Royal Society of Chemistry |
record_format | MEDLINE/PubMed |
spelling | pubmed-81532462021-06-11 Targeting structural features of viral genomes with a nano-sized supramolecular drug Melidis, Lazaros Styles, Iain B. Hannon, Michael J. Chem Sci Chemistry RNA targeting is an exciting frontier for drug design. Intriguing targets include functional RNA structures in structurally-conserved untranslated regions (UTRs) of many lethal viruses. However, computational docking screens, valuable in protein structure targeting, fail for inherently flexible RNA. Herein we harness MD simulations with Markov state modeling to enable nanosize metallo-supramolecular cylinders to explore the dynamic RNA conformational landscape of HIV-1 TAR untranslated region RNA (representative for many viruses) replicating experimental observations. These cylinders are exciting as they have unprecedented nucleic acid binding and are the first supramolecular helicates shown to have anti-viral activity in cellulo: the approach developed in this study provides additional new insight about how such viral UTR structures might be targeted with the cylinder binding into the heart of an RNA-bulge cavity, how that reduces the conformational flexibility of the RNA and molecular details of the insertion mechanism. The approach and understanding developed represents a new roadmap for design of supramolecular drugs to target RNA structural motifs across biology and nucleic acid nanoscience. The Royal Society of Chemistry 2021-04-05 /pmc/articles/PMC8153246/ /pubmed/34123344 http://dx.doi.org/10.1039/d1sc00933h Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/ |
spellingShingle | Chemistry Melidis, Lazaros Styles, Iain B. Hannon, Michael J. Targeting structural features of viral genomes with a nano-sized supramolecular drug |
title | Targeting structural features of viral genomes with a nano-sized supramolecular drug |
title_full | Targeting structural features of viral genomes with a nano-sized supramolecular drug |
title_fullStr | Targeting structural features of viral genomes with a nano-sized supramolecular drug |
title_full_unstemmed | Targeting structural features of viral genomes with a nano-sized supramolecular drug |
title_short | Targeting structural features of viral genomes with a nano-sized supramolecular drug |
title_sort | targeting structural features of viral genomes with a nano-sized supramolecular drug |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153246/ https://www.ncbi.nlm.nih.gov/pubmed/34123344 http://dx.doi.org/10.1039/d1sc00933h |
work_keys_str_mv | AT melidislazaros targetingstructuralfeaturesofviralgenomeswithananosizedsupramoleculardrug AT stylesiainb targetingstructuralfeaturesofviralgenomeswithananosizedsupramoleculardrug AT hannonmichaelj targetingstructuralfeaturesofviralgenomeswithananosizedsupramoleculardrug |